Immunome Stock Technical Analysis
| IMNM Stock | USD 22.12 0.32 1.47% |
As of the 25th of February, Immunome retains the Risk Adjusted Performance of 0.0789, downside deviation of 4.38, and Market Risk Adjusted Performance of 0.3698. Immunome technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Immunome coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Immunome is priced fairly, providing market reflects its last-minute price of 22.12 per share. Given that Immunome has jensen alpha of 0.3166, we strongly advise you to confirm Immunome's regular market performance to make sure the company can sustain itself at a future point.
Immunome Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immunome, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmunomeImmunome's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Immunome Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 35.08 | Strong Buy | 9 | Odds |
Most Immunome analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunome stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunome, talking to its executives and customers, or listening to Immunome conference calls.
Will Biotechnology sector continue expanding? Could Immunome diversify its offerings? Factors like these will boost the valuation of Immunome. Market participants price Immunome higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immunome data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.96) | Revenue Per Share | Quarterly Revenue Growth 0.698 | Return On Assets | Return On Equity |
Understanding Immunome requires distinguishing between market price and book value, where the latter reflects Immunome's accounting equity. The concept of intrinsic value - what Immunome's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immunome's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immunome's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Immunome 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunome's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunome.
| 11/27/2025 |
| 02/25/2026 |
If you would invest 0.00 in Immunome on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Immunome or generate 0.0% return on investment in Immunome over 90 days. Immunome is related to or competes with Creative Medical, Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious di... More
Immunome Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunome's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunome upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.38 | |||
| Information Ratio | 0.0705 | |||
| Maximum Drawdown | 31.45 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 7.47 |
Immunome Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunome's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunome's standard deviation. In reality, there are many statistical measures that can use Immunome historical prices to predict the future Immunome's volatility.| Risk Adjusted Performance | 0.0789 | |||
| Jensen Alpha | 0.3166 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0759 | |||
| Treynor Ratio | 0.3598 |
Immunome February 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0789 | |||
| Market Risk Adjusted Performance | 0.3698 | |||
| Mean Deviation | 3.34 | |||
| Semi Deviation | 4.07 | |||
| Downside Deviation | 4.38 | |||
| Coefficient Of Variation | 1088.4 | |||
| Standard Deviation | 4.72 | |||
| Variance | 22.3 | |||
| Information Ratio | 0.0705 | |||
| Jensen Alpha | 0.3166 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0759 | |||
| Treynor Ratio | 0.3598 | |||
| Maximum Drawdown | 31.45 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 7.47 | |||
| Downside Variance | 19.23 | |||
| Semi Variance | 16.52 | |||
| Expected Short fall | (3.66) | |||
| Skewness | 0.2237 | |||
| Kurtosis | 3.08 |
Immunome Backtested Returns
Immunome appears to be not too volatile, given 3 months investment horizon. Immunome holds Efficiency (Sharpe) Ratio of 0.0872, which attests that the entity had a 0.0872 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Immunome, which you can use to evaluate the volatility of the firm. Please utilize Immunome's Market Risk Adjusted Performance of 0.3698, risk adjusted performance of 0.0789, and Downside Deviation of 4.38 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Immunome holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of 1.18, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immunome will likely underperform. Please check Immunome's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Immunome's current trending patterns will revert.
Auto-correlation | 0.44 |
Average predictability
Immunome has average predictability. Overlapping area represents the amount of predictability between Immunome time series from 27th of November 2025 to 11th of January 2026 and 11th of January 2026 to 25th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunome price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Immunome price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 3.46 |
Immunome technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Immunome Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Immunome across different markets.
About Immunome Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunome on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunome based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunome price pattern first instead of the macroeconomic environment surrounding Immunome. By analyzing Immunome's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunome's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunome specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 6.63 | 4.08 | 3.67 | 4.22 | Net Debt To EBITDA | 3.47 | 0.92 | 0.82 | 1.09 |
Immunome February 25, 2026 Technical Indicators
Most technical analysis of Immunome help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunome from various momentum indicators to cycle indicators. When you analyze Immunome charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0789 | |||
| Market Risk Adjusted Performance | 0.3698 | |||
| Mean Deviation | 3.34 | |||
| Semi Deviation | 4.07 | |||
| Downside Deviation | 4.38 | |||
| Coefficient Of Variation | 1088.4 | |||
| Standard Deviation | 4.72 | |||
| Variance | 22.3 | |||
| Information Ratio | 0.0705 | |||
| Jensen Alpha | 0.3166 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0759 | |||
| Treynor Ratio | 0.3598 | |||
| Maximum Drawdown | 31.45 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 7.47 | |||
| Downside Variance | 19.23 | |||
| Semi Variance | 16.52 | |||
| Expected Short fall | (3.66) | |||
| Skewness | 0.2237 | |||
| Kurtosis | 3.08 |
Immunome February 25, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immunome stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 14,835 | ||
| Daily Balance Of Power | 0.52 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 22.39 | ||
| Day Typical Price | 22.30 | ||
| Price Action Indicator | (0.10) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunome. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Biotechnology sector continue expanding? Could Immunome diversify its offerings? Factors like these will boost the valuation of Immunome. Market participants price Immunome higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immunome data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.96) | Revenue Per Share | Quarterly Revenue Growth 0.698 | Return On Assets | Return On Equity |
Understanding Immunome requires distinguishing between market price and book value, where the latter reflects Immunome's accounting equity. The concept of intrinsic value - what Immunome's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immunome's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immunome's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.